Predictors of Outcomes in Prurigo Nodularis in Patients Living With HIV: A Scoping Review.
作者信息
Mehta Shanti, Metko Dea, Seigel Kyle, Shamma Dalia, Piguet Vincent, Croitoru David
机构信息
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
出版信息
J Cutan Med Surg. 2024 Nov-Dec;28(6):601-602. doi: 10.1177/12034754241274345. Epub 2024 Aug 28.
Abstract
摘要
相似文献
1
Predictors of Outcomes in Prurigo Nodularis in Patients Living With HIV: A Scoping Review.HIV感染者结节性痒疹预后的预测因素：一项范围综述
J Cutan Med Surg. 2024 Nov-Dec;28(6):601-602. doi: 10.1177/12034754241274345. Epub 2024 Aug 28.
2
Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.在法属圭亚那，结节性痒疹和带状疱疹对 HIV 感染和需要 HAART 的免疫抑制的预测价值。
Trans R Soc Trop Med Hyg. 2011 Jul;105(7):401-4. doi: 10.1016/j.trstmh.2011.04.001. Epub 2011 May 28.
3
Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.沙利度胺治疗人类免疫缺陷病毒感染患者的结节性痒疹：疗效及神经病变风险
Arch Dermatol. 2004 Jul;140(7):845-9. doi: 10.1001/archderm.140.7.845.
4
Tofacitinib for Prurigo Nodularis: A Case Report.托法替布治疗结节性痒疹：一例报告
Clin Cosmet Investig Dermatol. 2022 Mar 21;15:503-506. doi: 10.2147/CCID.S354025. eCollection 2022.
5
Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.德国结节性痒疹与银屑病的流行病学比较：一项索赔数据库分析。
Acta Derm Venereol. 2020 Nov 4;100(18):adv00309. doi: 10.2340/00015555-3655.
6
Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide.低剂量沙利度胺治疗台湾特发性结节性瘙痒症患者
J Dermatol. 2007 Apr;34(4):237-42. doi: 10.1111/j.1346-8138.2007.00260.x.
7
Prurigo nodularis: a review.结节性痒疹：综述
Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. doi: 10.1111/j.1440-0960.2005.00187.x.
8
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.人源单克隆抑瘤素M受体β抗体维卡瑞单抗治疗中度至重度结节性痒疹的疗效和安全性：一项随机、双盲、安慰剂对照的2a期研究
EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar.
9
Epidemiology of prurigo nodularis in England: a retrospective database analysis.结节性痒疹在英格兰的流行病学：一项回顾性数据库分析。
Br J Dermatol. 2022 Aug;187(2):188-195. doi: 10.1111/bjd.21032. Epub 2022 May 9.
10
Epidemiology and Severity of Prurigo Nodularis in Europe: A Literature Review with an Application to Italian Data.欧洲结节性痒疹的流行病学与严重程度：一项文献综述及意大利数据应用
Dermatol Pract Concept. 2025 Apr 1;15(2):4716. doi: 10.5826/dpc.1502a4716.
本文引用的文献
1
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
2
Clinical analysis of skin lesions in 796 Chinese HIV- positive patients.796 例中国 HIV 阳性患者皮损的临床分析。
Acta Derm Venereol. 2011 Sep;91(5):552-6. doi: 10.2340/00015555-1107.
3
Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.对开始使用雷特格韦联合治疗有反应的持久性结节性痒疹。
Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128.
4
Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide.艾滋病中的结节性痒疹和光敏反应：沙利度胺治疗
J Am Acad Dermatol. 1995 Nov;33(5 Pt 1):837-8. doi: 10.1016/0190-9622(95)91846-9.
Zotero 插件